Beneficial Ownership of Registrable Securities. (a) Type and Number of Registrable Securities beneficially owned:
Beneficial Ownership of Registrable Securities. (a) Type and Number of Registrable Securities beneficially owned: -------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------
Beneficial Ownership of Registrable Securities. This question covers beneficial ownership of the Company's securities.
Beneficial Ownership of Registrable Securities. (a) Type and Number of Registrable Securities beneficially owned: ____________________________ ____________________________ ____________________________
Beneficial Ownership of Registrable Securities. Number of Shares of Registrable Securities beneficially owned(1) and purchased pursuant to the Subscription Agreement:
Beneficial Ownership of Registrable Securities. (a) Type and number of Registrable Securities beneficially owned (describe nature of ownership and whether voting or investment power over such Registrable Securities is shared):
Beneficial Ownership of Registrable Securities. (a) Total number of shares of Common Stock to be beneficially owned as March 31, 2024 (including shares of Common Stock that the undersigned has the right to acquire beneficial ownership, as specified in Rule 13d-3(d)(1) under the Exchange Act):
Beneficial Ownership of Registrable Securities. Issued Pursuant to the Agreement:
Beneficial Ownership of Registrable Securities. (a) Type and Number of Registrable Securities beneficially owned (list all shares of Avalon Pharmaceuticals, Inc. Common Stock that you currently own):
Beneficial Ownership of Registrable Securities. (a) Type and Number of Registrable Securities beneficially owned (list all shares of Clinical Data, Inc. Common Stock that you currently own):
